The invention discloses a pharmaceutical composition containing dronedarone, characterized in that it comprises dronedarone with antiarrythmic activity or one of its pharmaceutically acceptable salts, as active principle, a pharmaceutically acceptable amphiphilic lipid surfactants and phospholipids, optionally associated with one or several pharmaceutical additives.
